- Home
- ABVC vs KRRO Comparison
ABVC vs KRRO Comparison
Compare ABVC & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- KRRO
- Stock Information
- Founded
- ABVC 2015
- KRRO 2014
- Country
- ABVC United States
- KRRO United States
- Employees
- ABVC N/A
- KRRO N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- ABVC Health Care
- KRRO Health Care
- Exchange
- ABVC Nasdaq
- KRRO Nasdaq
- Market Cap
- ABVC 68.7M
- KRRO 58.6M
- IPO Year
- ABVC N/A
- KRRO 2019
- Fundamental
- Price
- ABVC $2.48
- KRRO $5.72
- Analyst Decision
- ABVC
- KRRO Buy
- Analyst Count
- ABVC 0
- KRRO 10
- Target Price
- ABVC N/A
- KRRO $74.17
- AVG Volume (30 Days)
- ABVC 62.5K
- KRRO 1.0M
- Earning Date
- ABVC 11-03-2025
- KRRO 11-12-2025
- Dividend Yield
- ABVC N/A
- KRRO N/A
- EPS Growth
- ABVC N/A
- KRRO N/A
- EPS
- ABVC N/A
- KRRO N/A
- Revenue
- ABVC $797,916.00
- KRRO $7,371,000.00
- Revenue This Year
- ABVC $735.18
- KRRO $116.91
- Revenue Next Year
- ABVC N/A
- KRRO N/A
- P/E Ratio
- ABVC N/A
- KRRO N/A
- Revenue Growth
- ABVC 56.52
- KRRO N/A
- 52 Week Low
- ABVC $0.40
- KRRO $5.61
- 52 Week High
- ABVC $5.48
- KRRO $56.69
- Technical
- Relative Strength Index (RSI)
- ABVC 37.24
- KRRO 21.00
- Support Level
- ABVC $2.77
- KRRO $5.82
- Resistance Level
- ABVC $3.06
- KRRO $6.59
- Average True Range (ATR)
- ABVC 0.17
- KRRO 1.57
- MACD
- ABVC -0.03
- KRRO -1.64
- Stochastic Oscillator
- ABVC 14.75
- KRRO 0.34
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.